Schedule 13D ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, $0.001 par value · CUSIP: 252828108
Event date: 2025-03-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avidity Partners Management LPReported CIK 0001791827
Shares: 3,378,939.00 · Class: 9.9%
- Avidity Partners Management (GP) LLCReported CIK 0001993910
Shares: 3,378,939.00 · Class: 9.9%
- Avidity Capital Partners Fund (GP) LP
Shares: 3,378,939.00 · Class: 9.9%
- Avidity Capital Partners (GP) LLC
Shares: 3,378,939.00 · Class: 9.9%
- Avidity Master Fund LP
Shares: 764,610.00 · Class: 2.3%
- Avidity Private Master Fund I LP
Shares: 2,749,625.00 · Class: 8.3%
- Michael GregoryReported CIK 0001993963
Shares: 3,378,939.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-002011
- Form type
- SCHEDULE 13D/A
- Filer
- Avidity Partners Management LP
- CIK
- CIK 1791827
- Filed
- Mar 19, 2025
- Reporting period
- Mar 17, 2025
- Description
- Schedule 13D beneficial ownership